{"entity":{"type":"insider","cik":"0001638380","url":"/insider/0001638380","json_url":"/insider/0001638380.json","name":"Ward Shane","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2017-01-31","last":"2025-12-12","span_basis":"filed_date"},"name_variants":[{"name":"Ward Shane","source":"filing","n_filings":9,"first_seen":"2017-01-31","last_seen":"2025-12-12"}],"transactions":[{"id":4675374,"accession":"0001610618-25-000100","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001610618-25-000100","line_url":"/filing/0001610618-25-000100#line-4","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001638380","owner_name":"Ward Shane","owner_display_name":"Ward Shane","owner_url":"/insider/0001638380","role":"Officer (COO & CLO)","role_mark":"O","role_mark_label":"Officer (COO & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CLO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9959.0,"shares_display":"9,959","price_per_share":220.077,"price_display":"220.08","price_state":"stated","total_value":2191746.843,"total_display":"2,191,746.84","total_whole":"2,191,747","shares_owned_after":25033.0,"shares_owned_after_display":"25,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-10","filed_date":"2025-12-12","scope":"insider"},{"id":5141845,"accession":"0001610618-25-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-25-000024","line_url":"/filing/0001610618-25-000024#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001638380","owner_name":"Ward Shane","owner_display_name":"Ward Shane","owner_url":"/insider/0001638380","role":"Officer (COO & CLO)","role_mark":"O","role_mark_label":"Officer (COO & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CLO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1664.0,"shares_display":"1,664","price_per_share":21.9604,"price_display":"21.96","price_state":"stated","total_value":36542.1056,"total_display":"36,542.11","total_whole":"36,542","shares_owned_after":14674.0,"shares_owned_after_display":"14,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-13","scope":"insider"},{"id":2429357,"accession":"0001610618-24-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-24-000012","line_url":"/filing/0001610618-24-000012#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001638380","owner_name":"Ward Shane","owner_display_name":"Ward Shane","owner_url":"/insider/0001638380","role":"Officer (COO & CLO)","role_mark":"O","role_mark_label":"Officer (COO & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CLO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20473.0,"shares_display":"20,473","price_per_share":0.6698,"price_display":"0.67","price_state":"stated","total_value":13712.8154,"total_display":"13,712.82","total_whole":"13,713","shares_owned_after":198770.0,"shares_owned_after_display":"198,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider"},{"id":7850178,"accession":"0001610618-23-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610618-23-000013","line_url":"/filing/0001610618-23-000013#line-1","is_derivative":false,"issuer_cik":"0001610618","issuer_name":"Cidara Therapeutics, Inc.","issuer_ticker":"CDTX","issuer_name_source":null,"issuer_url":"/issuer/0001610618","owner_cik":"0001638380","owner_name":"Ward Shane","owner_display_name":"Ward Shane","owner_url":"/insider/0001638380","role":"Officer (COO & CLO)","role_mark":"O","role_mark_label":"Officer (COO & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CLO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4329.0,"shares_display":"4,329","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":6623.37,"total_display":"6,623.37","total_whole":"6,623","shares_owned_after":84576.0,"shares_owned_after_display":"84,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-13","filed_date":"2023-03-13","scope":"insider"},{"id":8112792,"accession":"0001358403-19-000114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-19-000114","line_url":"/filing/0001358403-19-000114#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001638380","owner_name":"Ward Shane","owner_display_name":"Ward Shane","owner_url":"/insider/0001638380","role":"Officer (Sr. VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP and General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":1.2277,"price_display":"1.23","price_state":"stated","total_value":9821.6,"total_display":"9,821.60","total_whole":"9,822","shares_owned_after":18294.0,"shares_owned_after_display":"18,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-29","filed_date":"2019-08-30","scope":"insider"},{"id":6075257,"accession":"0001209191-18-009268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-009268","line_url":"/filing/0001209191-18-009268#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001638380","owner_name":"Ward Shane","owner_display_name":"Ward Shane","owner_url":"/insider/0001638380","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4118.0,"shares_display":"4,118","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":7412.4,"total_display":"7,412.40","total_whole":"7,412","shares_owned_after":201556.0,"shares_owned_after_display":"201,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-08","filed_date":"2018-02-12","scope":"insider"},{"id":5320743,"accession":"0001209191-17-057765","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-057765","line_url":"/filing/0001209191-17-057765#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001638380","owner_name":"Ward Shane","owner_display_name":"Ward Shane","owner_url":"/insider/0001638380","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":776.0,"shares_display":"776","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":1978.8,"total_display":"1,978.80","total_whole":"1,979","shares_owned_after":92574.0,"shares_owned_after_display":"92,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-19","filed_date":"2017-10-23","scope":"insider"},{"id":4903592,"accession":"0001209191-17-020868","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-020868","line_url":"/filing/0001209191-17-020868#line-2","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001638380","owner_name":"Ward Shane","owner_display_name":"Ward Shane","owner_url":"/insider/0001638380","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":776.0,"shares_display":"776","price_per_share":19.02,"price_display":"19.02","price_state":"stated","total_value":14759.52,"total_display":"14,759.52","total_whole":"14,760","shares_owned_after":36350.0,"shares_owned_after_display":"36,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-15","scope":"insider"},{"id":4903586,"accession":"0001209191-17-020868","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-020868","line_url":"/filing/0001209191-17-020868#line-1","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001638380","owner_name":"Ward Shane","owner_display_name":"Ward Shane","owner_url":"/insider/0001638380","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1265.0,"shares_display":"1,265","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":24035.0,"total_display":"24,035.00","total_whole":"24,035","shares_owned_after":37126.0,"shares_owned_after_display":"37,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-14","filed_date":"2017-03-15","scope":"insider"},{"id":4971046,"accession":"0001209191-17-006519","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-006519","line_url":"/filing/0001209191-17-006519#line-2","is_derivative":false,"issuer_cik":"0001513818","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001513818","owner_cik":"0001638380","owner_name":"Ward Shane","owner_display_name":"Ward Shane","owner_url":"/insider/0001638380","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1474.0,"shares_display":"1,474","price_per_share":13.852,"price_display":"13.85","price_state":"stated","total_value":20417.848,"total_display":"20,417.85","total_whole":"20,418","shares_owned_after":38391.0,"shares_owned_after_display":"38,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-30","filed_date":"2017-01-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001610618","name":"Cidara Therapeutics, Inc.","url":"/issuer/0001610618","role":"Officer (COO & CLO)","n_filings":4,"first_seen":"2023-03-13","last_seen":"2025-12-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001358403","name":"BELLICUM PHARMACEUTICALS, INC","url":"/issuer/0001358403","role":"Officer (Sr. VP and General Counsel)","n_filings":1,"first_seen":"2019-08-30","last_seen":"2019-08-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001513818","name":"Versartis, Inc.","url":"/issuer/0001513818","role":"Officer (SVP and General Counsel)","n_filings":4,"first_seen":"2017-01-31","last_seen":"2018-02-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001638380","retrieved_at":"2026-08-27T12:33:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}